Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVXLNASDAQ:LIFWNASDAQ:PHATNASDAQ:SY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVXLAnavex Life Sciences$9.09+0.7%$8.46$3.78▼$14.44$770.91M0.681.20 million shs1.61 million shsLIFWMSP Recovery$1.43-4.0%$1.43$1.43▼$14.55$9.38M-2.38640,072 shs27,165 shsPHATPhathom Pharmaceuticals$10.42-4.4%$5.23$2.21▼$19.71$760.97M0.081.51 million shs1.83 million shsSYSo-Young International$1.17+15.8%$0.87$0.66▼$1.26$102.45M1.01125,110 shs958,867 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVXLAnavex Life Sciences+0.66%+13.20%+16.84%-6.67%+134.28%LIFWMSP Recovery0.00%+0.70%-10.06%+10.00%-89.10%PHATPhathom Pharmaceuticals-4.40%-2.07%+167.18%+67.26%-12.22%SYSo-Young International+15.27%+21.99%+34.64%+13.59%+13.58%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVXLAnavex Life Sciences3.407 of 5 stars3.70.00.04.71.10.80.6LIFWMSP RecoveryN/AN/AN/AN/AN/AN/AN/AN/APHATPhathom Pharmaceuticals3.8258 of 5 stars4.52.00.00.01.95.00.6SYSo-Young International0.455 of 5 stars1.03.00.00.00.90.80.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVXLAnavex Life Sciences 3.33Buy$44.00384.05% UpsideLIFWMSP Recovery 0.00N/AN/AN/APHATPhathom Pharmaceuticals 3.00Buy$17.5067.95% UpsideSYSo-Young International 2.00Hold$0.80-31.62% DownsideCurrent Analyst Ratings BreakdownLatest LIFW, SY, AVXL, and PHAT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/9/2025PHATPhathom PharmaceuticalsCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$12.00 ➝ $17.006/9/2025PHATPhathom PharmaceuticalsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.006/6/2025PHATPhathom PharmaceuticalsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$28.005/2/2025PHATPhathom PharmaceuticalsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$10.00 ➝ $5.005/2/2025PHATPhathom PharmaceuticalsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$18.00 ➝ $12.005/2/2025PHATPhathom PharmaceuticalsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$28.00 ➝ $20.004/21/2025PHATPhathom PharmaceuticalsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$28.00 ➝ $28.004/17/2025PHATPhathom PharmaceuticalsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$12.00 ➝ $10.004/9/2025PHATPhathom PharmaceuticalsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$28.00 ➝ $28.004/7/2025AVXLAnavex Life SciencesHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$42.00 ➝ $42.004/7/2025AVXLAnavex Life SciencesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$46.00 ➝ $46.00(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVXLAnavex Life SciencesN/AN/AN/AN/A$1.42 per shareN/ALIFWMSP Recovery$10.73M0.87$35.75 per share0.04$255.48 per share0.01PHATPhathom Pharmaceuticals$55.25M13.17N/AN/A($3.71) per share-2.81SYSo-Young International$200.94M0.59$0.01 per share87.54$2.63 per share0.44Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVXLAnavex Life Sciences-$43M-$0.55N/AN/AN/AN/A-40.93%-36.38%8/5/2025 (Estimated)LIFWMSP Recovery-$56.35M-$142.50N/A∞N/A-906.67%-6.25%-2.39%8/12/2025 (Estimated)PHATPhathom Pharmaceuticals-$334.33M-$5.24N/AN/AN/A-422.42%N/A-90.11%8/6/2025 (Estimated)SYSo-Young International-$80.76M-$0.80N/A∞N/A-41.03%-2.14%-1.61%8/20/2025 (Estimated)Latest LIFW, SY, AVXL, and PHAT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/16/2025Q1 2025SYSo-Young International-$0.34-$0.04+$0.30-$0.04$293.76 million$40.95 million5/13/2025Q2 2025AVXLAnavex Life Sciences-$0.16-$0.13+$0.03-$0.13N/AN/A3/28/2025Q4 2024SYSo-Young International$0.0906-$0.07-$0.1606-$0.81$402.58 million$50.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVXLAnavex Life SciencesN/AN/AN/AN/AN/ALIFWMSP RecoveryN/AN/AN/AN/AN/APHATPhathom PharmaceuticalsN/AN/AN/AN/AN/ASYSo-Young InternationalN/AN/AN/AN/AN/ALatest LIFW, SY, AVXL, and PHAT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/28/2025SYSo-Young International--$0.02254/8/20254/8/20254/25/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVXLAnavex Life SciencesN/A6.746.74LIFWMSP Recovery0.850.010.01PHATPhathom PharmaceuticalsN/A3.583.54SYSo-Young InternationalN/A2.752.45Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVXLAnavex Life Sciences31.55%LIFWMSP Recovery3.77%PHATPhathom Pharmaceuticals99.01%SYSo-Young International35.31%Insider OwnershipCompanyInsider OwnershipAVXLAnavex Life Sciences11.40%LIFWMSP Recovery86.52%PHATPhathom Pharmaceuticals23.00%SYSo-Young International16.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVXLAnavex Life Sciences4085.37 million75.64 millionOptionableLIFWMSP Recovery36.56 million885,000OptionablePHATPhathom Pharmaceuticals11069.81 million53.76 millionOptionableSYSo-Young International1,800101.44 million84.50 millionNot OptionableLIFW, SY, AVXL, and PHAT HeadlinesRecent News About These CompaniesSo-Young International Inc.: So-Young Announces Extension of Plan to Implement ADS Ratio ChangeJune 20 at 3:54 PM | finanznachrichten.deSo-Young Announces Extension of Plan to Implement ADS Ratio ChangeJune 20 at 5:00 AM | prnewswire.comLifeMD (NASDAQ:LFMD) & So-Young International (NASDAQ:SY) Critical SurveyJune 20 at 2:23 AM | americanbankingnews.comSo-Young International (NASDAQ:SY) Stock Price Down 5% - Here's What HappenedJune 1, 2025 | marketbeat.comSo-Young announces plan to implement ADS ratio change, shares downMay 30, 2025 | msn.comSo-Young Announces Plan to Implement ADS Ratio ChangeMay 30, 2025 | prnewswire.comSo-Young International Inc. (NASDAQ:SY) Q1 2025 Earnings Call TranscriptMay 20, 2025 | insidermonkey.comQ1 2025 So-Young International Inc Earnings CallMay 17, 2025 | finance.yahoo.comSo-Young International reports Q1 revenue decline, shares edge lowerMay 16, 2025 | in.investing.comSo-Young International Inc. (SY) Q1 2025 Earnings Call TranscriptMay 16, 2025 | seekingalpha.comSo-Young Reports Unaudited First Quarter 2025 Financial ResultsMay 16, 2025 | prnewswire.comSo-Young to Report First Quarter 2025 Financial Results on May 16, 2025May 6, 2025 | prnewswire.comSo-Young International Inc. Files Its Annual Report on Form 20-FApril 18, 2025 | gurufocus.comSo-Young International Inc. Files Its Annual Report on Form 20-F | SY Stock NewsApril 18, 2025 | gurufocus.comSo-Young International Inc. Files Its Annual Report on Form 20-FApril 18, 2025 | prnewswire.comSo-Young controlling shareholder purchases $4.09M in sharesApril 2, 2025 | markets.businessinsider.comSo-Young’s CEO Increases Stake with Major Share PurchaseApril 2, 2025 | tipranks.comSo-Young International Inc. Announces Share Purchase by Controlling ShareholderApril 2, 2025 | prnewswire.comSo-Young International Inc.: So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial ResultsMarch 30, 2025 | finanznachrichten.deQ4 2024 So-Young International Inc Earnings CallMarch 29, 2025 | uk.finance.yahoo.comSo-Young International Inc. (NASDAQ:SY) Q4 2024 Earnings Call TranscriptMarch 29, 2025 | insidermonkey.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesThese ETFs Provide Easy Exposure to Growing International MarketsBy Nathan Reiff | May 24, 2025View These ETFs Provide Easy Exposure to Growing International MarketsAs Gold Surges, Albemarle Stock May Be the Next to PopBy Gabriel Osorio-Mazilli | June 10, 2025View As Gold Surges, Albemarle Stock May Be the Next to PopSynopsys Stock Falls on China Ban, But Long-Term Outlook HoldsBy Leo Miller | June 14, 2025View Synopsys Stock Falls on China Ban, But Long-Term Outlook HoldsCasey’s Surges on Strong Q4, More Gains Likely AheadBy Thomas Hughes | June 10, 2025View Casey’s Surges on Strong Q4, More Gains Likely AheadD-Wave Quantum Stock: Are Advantage2 Gains Here to Stay?By Nathan Reiff | May 28, 2025View D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay?LIFW, SY, AVXL, and PHAT Company DescriptionsAnavex Life Sciences NASDAQ:AVXL$9.09 +0.06 (+0.66%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$9.09 0.00 (0.00%) As of 06/20/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases. Its lead product candidate is ANAVEX 2-73 for the treatment of Alzheimer's disease and Parkinson's disease, as well as other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder; and infantile spasms, Fragile X syndrome, and Angelman syndrome. The company's drug candidate also comprises ANAVEX 3-71, which is in clinical trial for the treatment of schizophrenia, frontotemporal dementia, and Alzheimer's disease. Its preclinical drug candidates include ANAVEX 1-41 for the treatment of depression, stroke, and neurogenerative disease; ANAVEX 1066 for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York.MSP Recovery NASDAQ:LIFW$1.43 -0.06 (-4.03%) As of 06/13/2025MSP Recovery, Inc., doing business as LifeWallet, operates as a healthcare recovery and data analytics company in the United States and Puerto Rico. The company offers claims recovery services, including services to related parties or third parties to assist entities with pursuit of claims recovery rights. It also provides LifeWallet, a scalable and expandable data ecosystem where tokenized data is stored in a platform with multiple applications, including LifeWallet EHR for hospitals, medical providers, major medical laboratories, and governmental entities that gather and store electronic health records; Chase to Pay, a real-time, or near real-time analytics driven platform that identifies the proper primary payer at the point of care; LifeChain which is in development in order to tokenize healthcare claims and patient records using blockchain technology; LifeWallet 911 which is in development for utilization by emergency service organizations; LifeWallet Legal; LifeWallet Health; and LifeWallet Sports which connected brands with college athletes. MSP Recovery, Inc. was founded in 2014 and is headquartered in Coral Gables, Florida.Phathom Pharmaceuticals NASDAQ:PHAT$10.42 -0.48 (-4.40%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$10.50 +0.07 (+0.72%) As of 06/20/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.So-Young International NASDAQ:SY$1.17 +0.16 (+15.84%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$1.15 -0.02 (-1.71%) As of 06/20/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty which provides similar interfaces and functions as the mobile app, as well as serves as additional access points to the platform; and medical aesthetic community content through its website soyoung.com. It provides content in various media formats on its online platform generated by users, including professional generated, content from in-house editorial team that shares opinions on specific new medical procedures and trends; user generated content comprising Beauty Diaries that provides details about medical institution, doctor, price, and other information on the treatment; professional user generated, contents from the medical aesthetic influencers; and doctor generated, content from doctors to generate knowledge. In addition, the company offers consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and software as a service. Further, it engages in research and development, production, sales, and agency of laser and other optoelectronic medical beauty equipment; manufacture and sells light therapy device, surgical laser device and other equipment; internet information and technology advisory; online medical treatment and consultation; management consulting; internet culture; micro finance services, as well as sells cosmetics products. The company was founded in 2013 and is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Robinhood Director Sells Millions, But HOOD Stock Eyes Gains Coinbase Stock Pops as Senate Passes GENIUS Stablecoin Bill Overheated Market? Analysts Watch These Red Flags Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
